Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma

Clinical Cancer Research

Volumn 5, Issue 12, 1999, Pages 4005-4012

  Kondo, Motoi ^a   Yamamoto, Hirofumi ^a   Nagano, Hiroaki ^a   Okami, Jiro ^a   Ito, Yasuhiro ^a,b   Shimizu, Junzo ^a   Eguchi, Hidetoshi ^a   Miyamoto, Atsushi ^a   Dono, Keizo ^a   Umeshita, Koji ^a   Matsuura, Nariaki ^b   Wakasa, Ken Ichi ^c   Nakamori, Shoji ^a   Sakon, Masato ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; ARTICLE; CANCER SURVIVAL; CHRONIC HEPATITIS; CONTROLLED STUDY; DYSPLASIA; FEMALE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CYCLOOXYGENASE 2; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LIVER; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 17044453428     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Colombo, M. Hepatocellular carcinoma. J. Hepatol., 15: 225-236, 1992.
2. Okuda, K. Hepatocellular carcinoma: recent progress. Hepatology, 15: 948-963, 1992.
3. Ikeda, K., Saito, S., and Koida, I. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology, 18: 47-53, 1993.
4. Hla, T., and Neilson, K. Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. USA, 89: 7384-7388, 1992.
5. Jones, D. A., Carlton, D. P., McIntyre, T. M., Zimmerman, G. A., and Prescott, S. M. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J. Biol. Chem., 268: 9049-9054, 1993.
6. Hamasaki, Y., Kitzler, J., Hardman, R., Nettesheim, P., and Eling, T. E. Phorbol ester and epidermal growth factor enhance the expression of two inducible prostaglandin H synthase genes in rat tracheal epithelial cells. Arch. Biochem. Biophys., 304: 226-234, 1993.
7. DuBois, R. N., Awad, J., Morrow, J., Roberts, L. N., and Bishop, P. R. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J. Clin. Investig., 93: 493-498, 1994.
8. Kang, R. Y., Freire, M. J., Sigal, E., and Chu, C. Q. Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis. Br. J. Rheumatol., 35: 711-718, 1996.
9. Singer, I. I., Kawka, D. W., Schloemann, S., Tessner, T., Riehl, T., and Stenson, W. F. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology, 115: 297-306, 1998.
10. Sawaoka, H., Kawano, S., Tsuji, S., Tsuji, M., Sun, W., Gunawan, E. S., and Hori, M. Helicobacter pylori infection induces cyclooxygenase-2 expression in human gastric mucosa. Prostaglandins Leukotrienes Essent. Fatty Acids, 59: 313-316, 1998.
11. Labayle, D., Fischer, D., Vielh, P., Drouhin, F., Pariente, A., Bories, C., Duhamel, O., Trousset, M., and Attali, P. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology, 101: 635-639, 1991.
12. Thun, M. J., Namboodiri, M. M., and Heath, C. J. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 325: 1593-1596, 1991.
13. Schreinemachers, D. M., and Everson, R. B. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology, 5: 138-146, 1994.
14. Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., and Taketo, M. M. Suppression of intestinal polyposis in Ape Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87: 803-809, 1996.
15. Taketo, M. M. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). J. Natl. Cancer Inst., 90: 1609-1620, 1998.
16. Koga, H., Sakiska, S., Ohishi, M., Kawaguchi, T., Taniguchi, E., Sasatomi, K., Harada, M., Kusaba, T., Tanaka, M., Kimura, R., Nakashima, Y., Nakashima, O., Kojiro, M., Kurohiji, T., and Sata, M. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology, 29: 688-696, 1999.
17. Shiota, G., Okubo, M., Noumi, T., Noguchi, N., Oyama, K., Takano, Y., Yashima, K., Kishimoto, Y., and Kawasaki, H. Cyclooxygenase-2 expression in hepatocellular carcinoma. Hepatogastroenterology, 46: 407-412, 1999.
18. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., and DuBois, R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107: 1183-1188, 1994.
19. Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., and Hla, T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55: 3785-3789, 1995.
20. Ristimaki, A., Honkanen, N., Jankala, H., Sipponen, P., and Harkonen, M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res., 57: 1276-1280, 1997.
21. Hwang, D., Scollard, D., Byrne, J., and Levine, E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J. Natl. Cancer Inst., 90: 455-460, 1998.
22. Wilson, K. T., Fu, S., Ramanujam, K. S., and Meltzer, S. J. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res., 58: 2929-2934, 1998.
23. Hida, T., Yatabe, Y., Achiwa, H., Muramatsu, H., Kozaki, K., Nakamura, S., Ogawa, M., Mitsudomi, T., Sugiura, T., and Takahashi, T. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res., 58: 3761-3764, 1998.
24. Wolff, H., Saukkonen, K., Anttila, S., Karjalainen, A., Vainio, H., and Ristimaki, A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res., 58: 4997-5001, 1998.
25. Fujita, T., Matsui, M., Takaku, K., Uetake, H., Ichikawa, W., Taketo, M. M., and Sugihara, K. Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. Cancer Res., 58: 4823-4826, 1998.
26. Zimmermann, K. C., Sarbia, M., Weber, A. A., Borchard, F., Gabbert, H. E., and Schror, K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res., 59; 198-204, 1999.
27. Tucker, O. N., Dannenberg, A. J., Yang, E. K., Zhang, F., Teng, L., Daly, J. M., Soslow, R. A., Masferrer, J. L., Woerner, B. M., Koki, A. T., and Fahey, T. R. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res., 59: 987-990, 1999.
28. Okami, J., Yamamoto, H., Fujiwara, Y., Tsujie, M., Kondo, M., Noura, S., Oshima, S., Nagano, H., Dono, K., Umeshita, K., Ishikawa, O., Sakon, M., Matsuura, N., Nakamori, S., and Monden, M. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. Clin. Cancer Res., 5: 2018-2024, 1999.
29. Vane, J. Suppression of intestinal polyposis by inhibition of COX-2 in Ape knockout mice. Jpn. J. Cancer Res., 88: 1244-1245, 1997.
30. Fukutake, M., Nakatsugi, S., Isoi, T., Takahashi, M., Ohta, T., Mamiya, S., Taniguchi, Y., Sato, H., Fukuda, K., Sugimura, T., and Wakabayashi, K. Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice. Carcinogenesis (Lond.), 19: 1939-1942, 1998.
31. Nakatsugi, S., Fukutake, M., Takahashi, M., Fukuda, K., Isoi, T., Taniguchi, Y., Sugimura, T., and Wakabayashi, K. Suppression of intestinal polyp development by nimesulide, a selective cyclooxygenase-2 inhibitor, in Min mice. Jpn. J. Cancer Res., 88: 1117-1120, 1997.
32. Kawamori, T., Rao, C. V., Seibert, K., and Reddy, B. S. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res., 58: 409-412, 1998.
33. Reddy, B. S., Rao, C. V., and Seibert, K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res., 56: 4566-4569, 1996.
34. Rioux, N., and Castonguay, A. Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398. Cancer Res., 58: 5354-5360, 1998.
35. Sheng, H., Shao, J., Kirkland, S. C., Isakson, P., Coffey, R. J., Morrow, J., Beauchamp, R. D., and DuBois, R. N. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Investig., 99: 2254-2259, 1997.
36. Hara, A., Yoshimi, N., Niwa, M., Ino, N., and Mori, H. Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines. Jpn. J. Cancer Res., 88: 600-604, 1997.
37. Sawaoka, H., Kawano, S., Tsuji, S., Tsujii, M., Gunawan, E. S., Takei, Y., Nagano, K., and Hori, M. Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am. J. Physiol., 274: G1061-G1067, 1998.
38. Lui, X. H., Yao, S., Kirschenbaum, A., and Levine, A. C. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res., 58: 4245-4249, 1998.
39. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
40. Nagel, S., Schmidt, M., Thiede, C., Huhn, D., and Neubauer, A. Quantification of Bcr-Abl transcripts in chronic myelogenous leukemia (CML) using standardized, internally controlled, competitive differential PCR (CD-PCR). Nucleic Acids Res., 24: 4102-4103, 1996.
41. Chretien, S., Dubart, A., Beaupain, D., Raich, N., Grandchamp, B., Rosa, J., Goossens, M., and Romeo, P. H. Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression. Proc. Natl. Acad. Sci. USA, 85: 6-10, 1988.
42. O'Neill, G. P., and Ford, H. A. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett., 330: 156-160, 1993.
43. Finke, J., Fritzen, R., Ternes, P., Lange, W., and Dolken, G. An improved strategy and a useful housekeeping gene for RNA analysis from formalin-fixed, paraffin-embedded tissues by PCR. Biotechniques, 14: 448-453, 1993.
44. Ciaparrone, M., Yamamoto, H., Yao, Y., Sgambato, A., Cattoretti, G., Tomita, N., Monden, T., Rotterdam, H., and Weinstein, I. B. Localization and expression of p27KIP1 in multistage colorectal carcinogenesis. Cancer Res., 58: 114-122, 1998.
45. Short, B. G., Zimmerman, D. M., and Schwartz, L. W. Automated double labeling of proliferation and apoptosis in glutathione S-transferase-positive hepatocytes in rats. J. Histochem. Cytochem., 45: 1299-1305, 1997.
46. Yamamoto, H., Soh, J. W., Shirin, H., Xing, W. Q., Lim, J. T., Yao, Y., Slosberg, E., Tomita, N., Schieren, I., and Weinstein, I. B. Comparative effects of overexpression of p27Kip1 and p21Cip1/Waf1 on growth and differentiation in human colon carcinoma cells. Oncogene, 18: 103-115, 1999.
47. Morales-Ruiz, M., Jimenez, W., Perez, Sala, D., Ros, J., Leivas, A., Lamas, S., Rivera, F., and Arroyo, V. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. Hepatology, 24: 1481-1486, 1996.
48. Schmedtje, J. F., Jr., Ji, Y. S., Liu, W. L., DuBois, R. N., and Runge, M. S. Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells. J. Biol. Chem., 272: 601-608, 1997.
49. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., and DuBois, R. N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93: 705-716, 1998.
50. El-Assal, O. N., Yamanoi, A., Yamaguchi, M., Igarashi, M., Yamamoto, A., Nabika, T., and Nagasoe, N. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factors in angiogenesis of cirrhotic liver. Hepatology, 27: 1554-1562, 1998.
51. Wu, C. C., Chen, J. T., Ho, W. L., Yeh, D. C., Tang, J. S., Liu, T. J., and P'eng, F. K. Liver resection for hepatocellular carcinoma in octogenarians. Surgery, 125: 332-338, 1999.
52. Tarao, K., Hoshino, H., Shimizu, A., Ohkawa, S., Nakamura, Y., Harada, M., Ito, Y., Tamai, S., Akaike, M., and Sugimasa, Y. Role of increased DNA synthesis activity of hepatocytes in multicentric hepatocarcinogenesis in residual liver of hepatectomized cirrhotic patients with hepatocellular carcinoma. Jpn. J. Cancer Res., 85: 1040-1044, 1994.
53. Tarao, K., Takemiya, S., Tamai, S., Sugimasa, Y., Ohkawa, S., Akaike, M., Tanabe, H., Shimizu, A., Yoshida, M., and Kakita, A. Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC. Cancer (Phila.), 79: 688-694, 1997.
54. Ko, S., Nakajima, Y., and Kanehiro, H. Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Ann. Surg, 224: 591-595, 1996.
55. Ko, S., Nakajima, Y., Kanehiro, H., Kin, T., Aomatsu, Y., Yoshimura, A., Taki, J., Yagura, K., Ohashi, K., and Nakano, H. Influence of associated viral hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. World J. Surg., 21: 1082-1086, 1996.
56. Bosch-Marce, M., Claria, J., Titos, E., Masferrer, J. L., Altuna, R., Poo, J. L., Jimenez, W., Arroyo, V., Rivera, F., and Rodes, J. Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites. Gastroenterology, 116: 1167-1175, 1999.
57. Takayama, T., Makuuchi, M., Hirohashi, S., Sakamoto, M., Okazaki, N., Takayasu, K., Kosuge, T., Motoo, Y., and Yamazaki, S. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet, 336: 1150-1153, 1990.
58. Denda, A., Endoh, T., Kitayama, W., Tang, Q., Noguchi, O., Kobayashi, Y., Akai, H., Okajima, E., Tsujiuchi, T., Tsutsumi, M., Nakae, D., and Konishi, Y. Inhibition by piroxicam of oxidative DNA damage, liver cirrhosis and development of enzyme-altered nodules caused by a choline-deficient, L-amino acid-defined diet in rats. Carcinogenesis (Lond.), 18: 1921-1930, 1997.
59. Goldman, A. P., Williams, C. S., Sheng, H., Lamps, L. W., Williams, V. P., Pairet, M., Morrow, J. D., and DuBois, R. N. Meloxicam inhibits the growth of colorectal cancer cells. Carcinogenesis (Lond.), 19: 2195-2199, 1998.
60. Bracken, K. E., Elger, W., Jantke, I., Nanninga, A., and Gellersen, B. Cloning of guinea pig cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase complementary deoxyribonucleic acids: steroidmodulated gene expression correlates to prostaglandin F2α secretion in cultured endometrial cells. Endocrinology, 138: 237-247, 1997.
61. Leong, J., Hughes, Fulford, M., Rakhlin, N., Habib, A., Maclouf, J., and Goldyne, M. E. Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation. Exp. Cell Res., 224: 79-87, 1996.
62. Sugihara, S., Nakashima, O., Kojiro, M., Majima, Y., Tanaka, M., and Tanikawa, K. The morphologic transition in hepatocellular carcinoma: a comparison of the individual histologic features disclosed by ultrasound-guided fine-needle biopsy with those of autopsy. Cancer (Phila.), 70: 1488-1492, 1992.